Cancer Incidence and Mortality for All Sites of Cancer, Richmond County (Staten Island), 2011-2015

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 2843.0 524.9 516.1-533.8 1399.6 577.1 563.2-591.2 1443.4 491.5 479.9-503.2 817.2 151.9 147.2-156.8 416.2 184.0 176.0-192.4 401.0 130.4 124.7-136.4
Oral cavity and pharynx
All Oral cavity and pharynx 56.4 10.0 8.8-11.3 38.4 14.9 12.8-17.2 18.0 6.0 4.8-7.4 9.2 1.6 1.2-2.2 6.0 2.4 1.6-3.4 3.2 1.0 0.6-1.7
Lip 1.2 0.2 0.1-0.5 0.6 0.2 0.0-0.7 0.6 0.2 0.0-0.7 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Tongue 16.6 3.0 2.3-3.7 12.0 4.7 3.5-6.1 4.6 1.6 1.0-2.4 2.6 0.5 0.2-0.8 1.8 0.7 0.3-1.3 0.8 0.3 0.1-0.7
Salivary gland 6.6 1.2 0.8-1.7 3.8 1.6 0.9-2.5 2.8 0.9 0.5-1.6 0.6 0.1 0.0-0.3 0.4 0.2 0.0-0.7 0.2 0.1 0.0-0.4
Floor of mouth 2.0 0.3 0.2-0.7 1.8 0.7 0.3-1.4 0.2 0.1 0.0-0.4 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Gum & other mouth 9.4 1.8 1.3-2.4 5.0 2.2 1.4-3.2 4.4 1.5 0.9-2.3 1.0 0.2 0.1-0.4 0.8 0.3 0.1-0.9 0.2 0.1 0.0-0.4
Nasopharynx 4.4 0.8 0.5-1.2 3.2 1.1 0.6-1.9 1.2 0.4 0.2-1.0 1.0 0.2 0.1-0.4 0.4 0.2 0.0-0.6 0.6 0.2 0.0-0.6
Tonsil 9.6 1.6 1.2-2.2 7.4 2.7 1.9-3.8 2.2 0.7 0.3-1.3 0.2 0.0 0.0-0.2 0.2 0.1 0.0-0.5 0.0 0.0 0.0-0.3
Oropharynx 2.2 0.4 0.2-0.7 1.6 0.6 0.3-1.2 0.6 0.2 0.0-0.6 0.8 0.1 0.0-0.4 0.4 0.2 0.0-0.6 0.4 0.1 0.0-0.5
Hypopharynx 2.6 0.4 0.2-0.8 2.2 0.8 0.4-1.5 0.4 0.1 0.0-0.5 0.2 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.2 0.1 0.0-0.4
Other buccal cavity and pharynx 1.8 0.3 0.1-0.6 0.8 0.3 0.1-0.7 1.0 0.3 0.1-0.8 2.8 0.5 0.3-0.9 2.0 0.8 0.4-1.5 0.8 0.3 0.1-0.7
Digestive system
All Digestive system 481.2 88.5 84.9-92.2 261.8 108.3 102.3-114.6 219.4 72.3 68.0-76.8 228.0 42.0 39.5-44.6 127.0 53.9 49.6-58.4 101.0 32.7 29.9-35.8
Esophagus 17.8 3.3 2.6-4.0 14.2 5.9 4.6-7.5 3.6 1.2 0.7-1.9 16.8 3.1 2.5-3.9 13.2 5.5 4.2-7.0 3.6 1.3 0.8-2.1
Stomach 44.4 8.3 7.2-9.5 25.0 10.6 8.7-12.7 19.4 6.5 5.3-8.0 20.2 3.6 2.9-4.3 12.4 5.2 3.9-6.7 7.8 2.3 1.6-3.2
Small intestine 13.6 2.4 1.9-3.1 7.2 2.9 2.0-4.1 6.4 2.0 1.4-2.9 0.8 0.1 0.0-0.4 0.4 0.1 0.0-0.6 0.4 0.1 0.0-0.5
Colorectal 233.0 43.3 40.8-45.9 116.6 49.4 45.3-53.7 116.4 38.2 35.1-41.6 84.8 15.9 14.4-17.6 40.4 18.2 15.7-21.0 44.4 14.3 12.4-16.4
Colon excluding rectum 167.0 31.2 29.1-33.5 80.2 34.5 31.1-38.2 86.8 28.4 25.8-31.3 71.6 13.6 12.2-15.1 33.6 15.3 13.0-17.9 38.0 12.2 10.5-14.2
Cecum 30.6 5.9 5.0-6.9 10.8 4.9 3.6-6.4 19.8 6.5 5.3-8.0                  
Appendix 4.6 1.0 0.6-1.5 1.2 0.6 0.2-1.2 3.4 1.3 0.8-2.2                  
Ascending colon 34.6 6.5 5.5-7.5 16.4 6.9 5.4-8.6 18.2 6.0 4.8-7.5                  
Hepatic flexure 7.2 1.4 1.0-2.0 4.2 2.0 1.2-3.1 3.0 1.0 0.6-1.7                  
Transverse colon 15.4 2.9 2.2-3.6 7.4 3.3 2.3-4.5 8.0 2.5 1.8-3.4                  
Splenic flexure 3.0 0.6 0.3-1.0 2.0 0.8 0.4-1.6 1.0 0.4 0.1-0.9                  
Descending colon 11.6 2.2 1.7-2.9 6.0 2.6 1.7-3.8 5.6 1.9 1.2-2.7                  
Sigmoid colon 48.8 8.8 7.7-10.0 27.0 11.2 9.3-13.3 21.8 6.9 5.7-8.4                  
Large intestine, NOS 11.2 2.0 1.5-2.7 5.2 2.3 1.5-3.4 6.0 1.8 1.2-2.7                  
Rectum & rectosigmoid 66.0 12.1 10.8-13.5 36.4 14.9 12.7-17.3 29.6 9.8 8.3-11.6 13.2 2.4 1.8-3.1 6.8 2.9 2.0-4.1 6.4 2.0 1.4-2.9
Rectosigmoid junction 21.8 4.2 3.4-5.1 9.8 4.1 3.0-5.5 12.0 4.2 3.2-5.4                  
Rectum 44.2 7.9 6.9-9.0 26.6 10.8 9.0-12.9 17.6 5.6 4.5-7.0                  
Anus, anal canal & anorectum 10.4 1.9 1.4-2.5 5.2 2.2 1.4-3.2 5.2 1.6 1.0-2.4 1.2 0.2 0.1-0.5 0.4 0.2 0.0-0.7 0.8 0.2 0.1-0.7
Liver and intrahepatic bile duct 60.6 10.5 9.4-11.8 44.6 17.0 14.7-19.4 16.0 5.3 4.2-6.6 39.6 7.1 6.1-8.2 29.2 11.6 9.7-13.7 10.4 3.5 2.6-4.6
Liver 49.8 8.6 7.6-9.8 38.2 14.3 12.3-16.5 11.6 3.9 2.9-5.1 30.4 5.4 4.6-6.4 23.2 9.2 7.5-11.1 7.2 2.4 1.7-3.4
Intrahepatic bile duct 10.8 1.9 1.4-2.5 6.4 2.7 1.8-3.9 4.4 1.4 0.9-2.1 9.2 1.7 1.2-2.2 6.0 2.4 1.6-3.5 3.2 1.1 0.6-1.8
Gallbladder 6.6 1.3 0.9-1.9 1.4 0.7 0.3-1.4 5.2 1.8 1.2-2.7 4.0 0.8 0.5-1.2 2.0 0.9 0.4-1.6 2.0 0.7 0.3-1.3
Other biliary 9.8 1.8 1.3-2.4 5.2 2.1 1.3-3.1 4.6 1.6 1.0-2.4 1.6 0.3 0.1-0.6 0.6 0.3 0.1-0.8 1.0 0.3 0.1-0.8
Pancreas 75.0 13.7 12.3-15.2 38.4 15.8 13.6-18.3 36.6 12.0 10.3-13.9 57.6 10.6 9.4-12.0 27.8 11.7 9.8-13.9 29.8 9.7 8.2-11.5
Retroperitoneum 2.4 0.5 0.3-0.9 1.2 0.5 0.2-1.2 1.2 0.5 0.2-1.1 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Peritoneum, omentum & mesentery 3.6 0.7 0.4-1.1 0.4 0.2 0.0-0.7 3.2 1.1 0.6-1.8 1.0 0.2 0.1-0.5 0.4 0.2 0.0-0.7 0.6 0.2 0.0-0.6
Other digestive organs 4.0 0.7 0.4-1.2 2.4 1.1 0.5-1.9 1.6 0.5 0.2-1.0 0.4 0.1 0.0-0.3 0.2 0.1 0.0-0.4 0.2 0.1 0.0-0.4
Respiratory system
All Respiratory system 381.2 70.1 66.9-73.4 201.8 85.0 79.6-90.6 179.4 59.2 55.3-63.3 225.8 41.8 39.3-44.4 122.0 53.1 48.8-57.6 103.8 33.9 31.0-37.0
Nasal cavity, middle ear & sinuses 5.8 1.1 0.7-1.6 3.8 1.7 1.0-2.7 2.0 0.7 0.3-1.4 0.4 0.1 0.0-0.3 0.2 0.1 0.0-0.4 0.2 0.1 0.0-0.5
Larynx 23.0 4.1 3.3-4.9 17.8 7.1 5.6-8.8 5.2 1.7 1.1-2.6 5.8 1.1 0.7-1.6 4.6 2.1 1.3-3.2 1.2 0.4 0.1-0.9
Lung and bronchus 351.6 64.7 61.7-67.9 180.0 76.1 71.1-81.4 171.6 56.5 52.7-60.5 219.6 40.6 38.2-43.1 117.2 50.9 46.7-55.3 102.4 33.4 30.5-36.5
Pleura 0.4 0.1 0.0-0.4 0.0 0.0 0.0-0.3 0.4 0.2 0.0-0.7 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Trachea, mediastinum, other respiratory 0.4 0.1 0.0-0.3 0.2 0.1 0.0-0.5 0.2 0.1 0.0-0.5 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Soft tissue, bone, and skin
Bones & joints 5.4 1.1 0.7-1.6 3.0 1.3 0.7-2.2 2.4 0.9 0.5-1.6 1.2 0.3 0.1-0.6 0.8 0.4 0.1-1.0 0.4 0.1 0.0-0.5
Soft tissue (including heart) 19.6 3.8 3.1-4.7 10.0 4.5 3.3-5.9 9.6 3.4 2.5-4.5 5.8 1.1 0.7-1.6 3.4 1.5 0.8-2.4 2.4 0.9 0.4-1.5
Skin~ 108.0 20.1 18.4-21.9 61.0 25.9 23.0-29.1 47.0 16.3 14.2-18.6 13.0 2.5 1.9-3.2 8.4 3.7 2.7-5.1 4.6 1.6 1.0-2.4
Melanoma of the skin 96.8 18.0 16.4-19.7 54.8 23.1 20.4-26.1 42.0 14.6 12.6-16.7 9.6 1.8 1.3-2.4 6.2 2.7 1.8-3.9 3.4 1.2 0.7-1.9
Breast
Breast 399.0 73.8 70.5-77.2 2.6 1.1 0.6-1.8 396.4 134.8 128.8-141.0 57.6 10.5 9.3-11.8 0.6 0.3 0.1-0.9 57.0 18.0 16.0-20.3
Female genital system
All Female genital system             179.4 60.0 56.1-64.2             50.8 16.4 14.4-18.6
Cervix uteri             19.8 7.4 5.9-9.0             7.4 2.5 1.7-3.5
Corpus uterus and NOS             108.6 35.4 32.4-38.6             17.4 5.7 4.5-7.0
Ovary             37.6 12.8 11.0-14.8             23.0 7.4 6.1-8.9
Vagina             2.6 0.8 0.4-1.4             1.2 0.4 0.1-0.8
Vulva             8.2 2.7 1.9-3.7             1.2 0.3 0.1-0.8
Other female genital organs             2.6 1.0 0.5-1.7             0.6 0.2 0.0-0.5
Male genital system
All Male genital system       342.8 133.0 126.6-139.7             36.4 18.5 15.9-21.4      
Prostate       325.6 125.4 119.2-131.9             35.6 18.1 15.5-21.0      
Testis       14.0 6.3 4.9-8.0             0.4 0.2 0.0-0.6      
Penis       2.4 1.0 0.5-1.7             0.4 0.2 0.0-0.7      
Other male genital organs       0.8 0.3 0.1-0.8             0.0 0.0 0.0-0.3      
Urinary system
All Urinary system 254.4 46.7 44.1-49.4 186.0 77.9 72.8-83.3 68.4 22.8 20.4-25.5 48.0 9.1 7.9-10.3 32.8 14.8 12.6-17.4 15.2 4.9 3.9-6.2
Urinary bladder (including in situ) 141.0 26.0 24.1-28.1 110.0 47.7 43.7-52.0 31.0 10.1 8.5-11.9 27.2 5.1 4.3-6.1 20.2 9.5 7.7-11.6 7.0 2.2 1.5-3.0
Kidney and renal pelvis 104.2 18.9 17.2-20.6 69.6 27.2 24.3-30.3 34.6 11.8 10.1-13.8 20.2 3.8 3.1-4.6 12.0 5.0 3.8-6.5 8.2 2.8 2.0-3.8
Ureter 4.4 0.9 0.6-1.4 2.6 1.3 0.7-2.3 1.8 0.6 0.3-1.2 0.4 0.1 0.0-0.3 0.4 0.2 0.0-0.8 0.0 0.0 0.0-0.3
Other urinary organs 4.8 0.9 0.6-1.3 3.8 1.7 1.0-2.7 1.0 0.3 0.1-0.8 0.2 0.0 0.0-0.2 0.2 0.1 0.0-0.4 0.0 0.0 0.0-0.3
Eye & orbit
Eye & orbit 5.4 1.0 0.7-1.5 2.4 1.1 0.5-1.9 3.0 1.0 0.5-1.6 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Brain and central nervous system
All Brain / other nervous system (all behaviors) 99.8 19.3 17.6-21.1 37.2 15.7 13.4-18.2 62.6 22.1 19.6-24.8 24.2 4.6 3.8-5.5 13.0 5.5 4.2-7.1 11.2 3.8 2.9-5.0
Malignant brain / other nervous system 34.4 6.8 5.8-8.0 17.6 7.7 6.1-9.5 16.8 6.1 4.8-7.6 21.2 4.1 3.3-4.9 11.4 4.9 3.7-6.4 9.8 3.3 2.4-4.4
Malignant brain 31.6 6.2 5.3-7.3 16.4 7.1 5.6-8.9 15.2 5.4 4.2-6.8                  
Malignant other nervous system 2.8 0.6 0.3-1.1 1.2 0.5 0.2-1.2 1.6 0.7 0.3-1.4                  
Benign brain / other nervous system* 65.4 12.5 11.1-13.9 19.6 8.0 6.5-9.8 45.8 16.0 13.9-18.3 3.0 0.6 0.3-0.9 1.6 0.6 0.3-1.3 1.4 0.5 0.2-1.1
Benign brain 6.2 1.4 0.9-1.9 3.0 1.3 0.7-2.2 3.2 1.4 0.8-2.3                  
Benign other nervous system 59.2 11.1 9.8-12.5 16.6 6.7 5.3-8.3 42.6 14.6 12.6-16.7                  
Endocrine system
All Endocrine system 174.4 34.2 31.9-36.6 47.6 19.4 16.9-22.1 126.8 48.0 44.2-52.0 4.0 0.8 0.5-1.2 1.6 0.6 0.2-1.2 2.4 0.9 0.5-1.6
Thyroid 169.4 33.2 30.9-35.5 45.2 18.3 16.0-21.0 124.2 47.0 43.2-50.9 2.2 0.4 0.2-0.7 1.2 0.4 0.1-1.0 1.0 0.4 0.1-0.9
Other endocrine (including thymus) 5.0 1.0 0.7-1.5 2.4 1.0 0.5-1.8 2.6 1.0 0.5-1.7 1.8 0.4 0.2-0.7 0.4 0.2 0.0-0.6 1.4 0.5 0.2-1.1
Lymphomas
All Lymphomas 147.2 28.1 26.0-30.2 77.6 33.0 29.7-36.6 69.6 24.2 21.6-26.9 27.0 5.1 4.3-6.1 16.2 7.5 5.9-9.4 10.8 3.6 2.7-4.7
Hodgkin lymphoma 18.8 3.9 3.2-4.8 9.8 4.1 3.0-5.5 9.0 3.7 2.7-5.0 1.8 0.3 0.2-0.7 1.0 0.5 0.2-1.1 0.8 0.3 0.1-0.7
Non-Hodgkin lymphomas 128.4 24.1 22.3-26.1 67.8 28.9 25.8-32.3 60.6 20.5 18.2-23.0 25.2 4.8 4.0-5.7 15.2 7.0 5.5-8.9 10.0 3.3 2.4-4.4
Myeloma
All Myeloma 48.0 8.8 7.7-10.0 28.8 12.3 10.3-14.6 19.2 6.1 4.9-7.5 12.4 2.4 1.8-3.1 6.0 2.7 1.8-3.9 6.4 2.1 1.5-3.1
Leukemias
All Leukemias 97.0 18.5 16.9-20.3 54.0 23.3 20.5-26.3 43.0 15.3 13.3-17.6 28.8 5.5 4.7-6.6 15.6 7.0 5.5-8.8 13.2 4.6 3.5-5.9
Lymphocytic leukemias 52.8 10.1 8.9-11.4 30.6 13.3 11.2-15.6 22.2 7.8 6.4-9.5 7.0 1.4 1.0-1.9 3.8 1.7 1.0-2.7 3.2 1.1 0.6-1.8
Acute lymphocytic leukemia 9.0 2.0 1.5-2.7 4.8 2.2 1.4-3.3 4.2 1.9 1.2-2.9 1.4 0.3 0.1-0.6 1.0 0.4 0.1-1.0 0.4 0.1 0.0-0.5
Chronic lymphocytic leukemia 40.8 7.4 6.4-8.6 23.2 10.0 8.2-12.0 17.6 5.8 4.6-7.2 5.4 1.0 0.7-1.5 2.6 1.2 0.6-2.1 2.8 1.0 0.5-1.6
Other lymphocytic leukemias 3.0 0.6 0.3-1.0 2.6 1.1 0.6-1.9 0.4 0.2 0.0-0.6 0.2 0.0 0.0-0.2 0.2 0.1 0.0-0.4 0.0 0.0 0.0-0.3
Myeloid and monocytic leukemias 39.4 7.6 6.5-8.7 21.6 9.3 7.6-11.3 17.8 6.5 5.2-8.1 16.2 3.1 2.5-3.9 9.2 4.0 2.9-5.5 7.0 2.5 1.7-3.5
Acute myeloid leukemia 24.4 4.7 3.9-5.7 12.0 5.2 3.9-6.8 12.4 4.6 3.5-6.0 14.0 2.7 2.1-3.5 7.6 3.4 2.4-4.8 6.4 2.3 1.6-3.3
Acute monocytic leukemia 1.0 0.2 0.1-0.5 0.6 0.3 0.1-0.8 0.4 0.1 0.0-0.5 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Chronic myeloid leukemia 11.6 2.2 1.6-2.8 7.6 3.1 2.2-4.4 4.0 1.4 0.8-2.2 1.0 0.2 0.1-0.5 0.8 0.4 0.1-0.9 0.2 0.1 0.0-0.4
Other myeloid/monocytic leukemias 2.4 0.5 0.2-0.9 1.4 0.7 0.3-1.4 1.0 0.4 0.1-0.9 1.2 0.2 0.1-0.4 0.8 0.3 0.1-0.7 0.4 0.1 0.0-0.5
Other leukemias 4.8 0.9 0.5-1.3 1.8 0.7 0.3-1.3 3.0 1.0 0.5-1.6 5.6 1.1 0.7-1.5 2.6 1.2 0.6-2.1 3.0 1.0 0.5-1.7
Other acute leukemias 1.6 0.3 0.1-0.6 0.2 0.1 0.0-0.4 1.4 0.5 0.2-1.0 2.0 0.4 0.2-0.7 0.4 0.2 0.0-0.7 1.6 0.5 0.2-1.1
Aleukemic, subacute, leukemia NOS 3.2 0.6 0.3-1.0 1.6 0.6 0.3-1.3 1.6 0.5 0.2-1.0 3.6 0.7 0.4-1.1 2.2 1.0 0.5-1.9 1.4 0.5 0.2-1.0
Mesothelioma
Mesothelioma 5.2 1.0 0.7-1.5 3.4 1.6 0.9-2.6 1.8 0.6 0.3-1.3                  
Kaposi sarcoma
Kaposi sarcoma 4.2 0.9 0.5-1.3 3.2 1.6 0.9-2.5 1.0 0.3 0.1-0.8                  
Myelodysplastic syndromes
Myelodysplastic syndromes 26.6 5.1 4.3-6.1 17.6 8.2 6.5-10.2 9.0 2.9 2.1-4.0                  
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 26.0 4.9 4.1-5.9 13.6 5.8 4.5-7.4 12.4 4.2 3.2-5.4                  
Ill defined and unspecified sites
Ill defined and unspecified sites 47.2 8.9 7.8-10.2 26.4 11.4 9.5-13.6 20.8 7.0 5.7-8.5 48.0 9.0 7.9-10.2 28.0 12.7 10.6-15.0 20.0 6.4 5.2-7.8

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2017.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.